A new approach to tackle childhood obesity
A New Technological Intervention to Address Childhood Obesity: Approach to Multidimensional Intervention
NA · Universidad de Córdoba · NCT06409962
This study is testing a new program in Spain that helps kids aged 6 to 16 with obesity by changing their diets, encouraging exercise, and getting their families involved to see if it improves their health and mobility.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 215 (estimated) |
| Ages | 6 Years to 16 Years |
| Sex | All |
| Sponsor | Universidad de Córdoba (other) |
| Locations | 1 site (Córdoba) |
| Trial ID | NCT06409962 on ClinicalTrials.gov |
What this trial studies
This intervention focuses on addressing childhood obesity in Spain, particularly in regions with high prevalence rates. It combines dietary modifications, increased physical activity, and family involvement to promote healthier lifestyles among children aged 6 to 16. The study aims to analyze the impact of obesity on health outcomes, including musculoskeletal development and mobility, using technological interventions. Echocardiography will be utilized for early detection of heart-related issues associated with obesity.
Who should consider this trial
Good fit: Ideal candidates for this study are children aged 6 to 16 who are students at the participating school and have parental consent.
Not a fit: Patients with metabolic diseases, such as diabetes or metabolic syndrome, or those with specific health issues related to intestinal integrity or skin problems may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly reduce obesity rates and improve overall health outcomes for children.
How similar studies have performed: Other studies have shown success with similar interventions aimed at reducing childhood obesity, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Students from the school * Pediatric from age 6 to 16 * Students from the school that confirmed approval * Signed informed consent by the minor * Signed informed consent by the minor's parents or guardians. Exclusion Criteria: * Presence of HbA1c levels below 5.7% * Presence of HbA1c levels above 6.4% * Presence of pathological metabolic diseases, such as diabetes or metabolic syndrome * Presence of other diseases related to intestinal integrity or skin issues. * Lack of the signed informed consent by the minor and legal guardian
Where this trial is running
Córdoba
- Colegio Virgen del Carmen — Córdoba, Spain (RECRUITING)
Study contacts
- Principal investigator: Manuel Vaquero Alvárez, MD, Msc, PhD — Maimónides Biomedical Research Institute of Córdoba
- Study coordinator: Manuel J Guzmán Roldán, Msc
- Email: jefaturadeprimaria@colegiovirgendelcarmen.com
- Phone: 0034 957482125
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Body Weight, Dyslipidemias, Musculoskeletal Diseases, pediatric, body mass index, intervention, anthopometric, blood pressure